1. Proteolysis in the Interstitium
    Salvatore V. Pizzo et al, 2016, Proteolysis in the Interstitial Space CrossRef
  2. Clinical Implications of Compounds Designed to Inhibit ECM‐Modifying Metalloproteinases
    Sabrina Amar et al, 2017, PROTEOMICS CrossRef
  3. Validating Cell Surface Proteases as Drug Targets for Cancer Therapy: What Do We Know, and Where Do We Go?
    Emile Verhulst et al, 2022, Cancers CrossRef
  4. Disruption of TACE-filamin interaction can inhibit TACE-mediated ectodomain shedding
    Yongcheol Cho et al, 2017, Biochemical and Biophysical Research Communications CrossRef
  5. ADAM17: An Emerging Therapeutic Target for Lung Cancer
    null Saad et al, 2019, Cancers CrossRef
  6. Long non-coding RNA CCAT1 promotes metastasis and poor prognosis in epithelial ovarian cancer
    Yuan Cao et al, 2017, Experimental Cell Research CrossRef
  7. Cell-Specific Functions of ADAM17 Regulate the Progression of Thoracic Aortic Aneurysm
    Mengcheng Shen et al, 2018, Circulation Research CrossRef
  8. ADAM proteases: Emerging role and targeting of the non-catalytic domains
    Nayanendu Saha et al, 2019, Cancer Letters CrossRef
  9. Free-flow zone electrophoresis facilitated proteomics analysis of heterogeneous subpopulations in H1299 lung cancer cells
    Amir Sohail et al, 2022, Analytica Chimica Acta CrossRef
  10. Long noncoding RNA SBF2-AS1 contributes to the growth and metastatic phenotypes of NSCLC via regulating miR-338-3p/ADAM17 axis
    Qi Chen et al, 2020, Aging CrossRef
  11. MicroRNA‐152 targets ADAM17 to suppress NSCLC progression
    Yunshu Su et al, 2014, FEBS Letters CrossRef
  12. ADAM17 promotes lymph node metastasis in gastric cancer via activation of the Notch and Wnt signaling pathways
    Wei Li et al, 2018, International Journal of Molecular Medicine CrossRef
  13. Novel Therapeutic Anti-ADAM17 Antibody A9(B8) Enhances EGFR-TKI–Mediated Anticancer Activity in NSCLC
    Zheng Yang et al, 2019, Translational Oncology CrossRef
  14. ADAM 17 selectively activates the IL ‐6 trans‐signaling/ ERK MAPK axis in KRAS ‐addicted lung cancer
    Mohamed I Saad et al, 2019, EMBO Molecular Medicine CrossRef
  15. Semaphorin 5A suppresses the proliferation and migration of lung adenocarcinoma cells
    Pin‑Hao Ko et al, 2019, International Journal of Oncology CrossRef
  16. Metallothinein 1E Enhances Glioma Invasion through Modulation Matrix Metalloproteinases-2 and 9 in U87MG Mouse Brain Tumor Model
    Hyuk Hur et al, 2016, Journal of Korean Neurosurgical Society CrossRef